Abstract
The bicyclic 2′-thio-LNA ribothymidine phosphoramidite (13) has been synthesised using a strategy making the synthesis of 2′-thio-LNA convergent
with the syntheses of LNA and 2′-amino-LNA. The key step was the formation of anhydro-nucleoside
4 that prevented unwanted oxetane (3) formation during debenzylation of the 3′-OBn group, while concomitantly furnishing
the necessary inversion of configuration at the C2′ position. No oxetane was observed
even under basic conditions. We believe that this is due to the rigid tricyclic anhydro-nucleoside
limiting the conformational freedom of the furanose, thereby preventing the formation
of a strained tetracyclic system. After removal of the benzyl protection group the
liberated 3′-OH group (5) was easily benzoylated (6) and the anhydro-nucleoside ring opened to give the threo configured nucleoside 7. The 2′-thio-LNA ribothymidine phosphoramidite was synthesised in 9 steps from anhydro-nucleoside
4 in 30% yield. The 2′-thio-LNA 5-methylcytidine phosphoramidite was synthesised from
nucleoside 12 using standard protocols.
Key words
nucleosides - bicyclic compounds - antisense agents - hydrogenations - bioorganic
chemistry
References
<A NAME="RT10403SS-1">1</A>
New address: Daniel Sejer Pedersen, Cambridge University, University Chemical Laboratory,
Lensfield Road, Cambridge CB2 1EW, UK.
<A NAME="RT10403SS-2">2</A>
LNA is defined as an oligonucleotide containing one or more 2′-O,4′-C-methylene-β-d-ribofuranosyl nucleotide mono-mers (LNA monomers).
[3]
[5]
For clarity the terms 2′-amino-LNA and 2′-thio-LNA are used herein for the LNA analogues,
where the 2′-oxygen has been substituted by a nitrogen atom or a sulfur atom.
<A NAME="RT10403SS-3">3</A>
Koshkin AA.
Singh SK.
Nielsen P.
Rajwanshi VK.
Kumar R.
Meldgaard M.
Olsen CE.
Wengel J.
Tetrahedron
1998,
54:
3607
<A NAME="RT10403SS-4">4</A>
Obika S.
Nanbu D.
Hari Y.
Andoh J.-I.
Morio K.
Doi T.
Imanishi T.
Tetrahedron Lett.
1998,
39:
5401
<A NAME="RT10403SS-5">5</A>
Singh SK.
Nielsen P.
Koshkin AA.
Wengel J.
Chem. Commun.
1998,
455
<A NAME="RT10403SS-6">6</A>
Braasch DA.
Corey R.
Chem. Biol.
2000,
55:
1
<A NAME="RT10403SS-7">7</A>
Braasch DA.
Corey DR.
Nucleic Acids Res.
2002,
30:
5160
<A NAME="RT10403SS-8">8</A>
Childs JL.
Disney MD.
Turner DH.
Proc. Natl. Acad. Sci. U.S.A.
2002,
99:
11091
<A NAME="RT10403SS-9">9</A>
Crinelli R.
Bianchi M.
Gentilini L.
Magnani M.
Nucleic Acids Res.
2002,
30:
2435
<A NAME="RT10403SS-10">10</A>
Elayadi AN.
Braasch DA.
Corey DR.
Biochemistry
2002,
41:
9973
<A NAME="RT10403SS-11">11</A>
Fluiter K.
ten Asbroek ALMA.
de Wissel MB.
Jakobs ME.
Wissenbach M.
Olsson H.
Olsson O.
Oerum H.
Baas F.
Nucleic Acids Res.
2003,
31:
953
<A NAME="RT10403SS-12">12</A>
Hertoghs KM.
Ellis JH.
Catchpole IR.
Nucleic Acids Res.
2003,
31:
5817
<A NAME="RT10403SS-13">13</A>
Kurreck J.
Wyszko E.
Gillen C.
Erdmann VA.
Nucleic Acids Res.
2002,
30:
1911
<A NAME="RT10403SS-14">14</A>
Petersen M.
Wengel J.
Trends Biotechnol.
2003,
21:
74
<A NAME="RT10403SS-15">15</A>
Kumar R.
Singh SK.
Koshkin AA.
Rajwanshi VK.
Meldgaard M.
Wengel J.
Bioorg. Med. Chem. Lett.
1998,
8:
2219
<A NAME="RT10403SS-16">16</A>
Singh SK.
Kumar R.
Wengel J.
J. Org. Chem.
1998,
63:
10035
<A NAME="RT10403SS-17">17</A>
Singh SK.
Kumar R.
Wengel J.
J. Org. Chem.
1998,
63:
6078
<A NAME="RT10403SS-18">18</A>
Wnuk SF.
Tetrahedron
1993,
49:
9877
<A NAME="RT10403SS-19">19</A>
Covés J.
Le Hir de Fallois L.
Le Pape L.
Décout J.-L.
Fontecave M.
Biochemistry
1996,
35:
8595
<A NAME="RT10403SS-20">20</A>
Roy B.
Chambert S.
Lepoivre M.
Aubertin A.-M.
Balzarini J.
Décout J.-L.
J. Med. Chem.
2003,
46:
2565
<A NAME="RT10403SS-21">21</A>
Prakash TP.
Manoharan M.
Kawasaki AM.
Fraser AS.
Lesnik EA.
Sioufi N.
Leeds JM.
Teplova M.
Egli M.
Biochemistry
2002,
41:
11642
<A NAME="RT10403SS-22">22</A>
Koshkin AA.
Fensholdt J.
Pfundheller HM.
Lomholt C.
J. Org. Chem.
2001,
66:
8504
<A NAME="RT10403SS-23">23</A>
Rosenbohm C.
Christensen SM.
Sørensen MD.
Pedersen DS.
Larsen L.-E.
Wengel J.
Koch T.
Org. Biomol. Chem.
2003,
1:
655
<A NAME="RT10403SS-24">24</A>
Pedersen DS.
Rosenbohm C.
Koch T.
Synthesis
2002,
802
<A NAME="RT10403SS-25">25</A>
Pedersen DS.
Rosenbohm C.
Synthesis
2001,
2431
<A NAME="RT10403SS-26">26</A>
Mestre-C 2.3a software, http://qubrue.usc.es/.